TY  - BOOK
AU  - Lotke, Pamela S
TI  - Safety and Efficacy of Contraceptive Methods for Obese and Overweight Women. [Review]
SN  - 0889-8545
KW  - *Contraceptive Agents, Female/ad [Administration & Dosage]
KW  - *Contraceptives, Oral, Hormonal/ad [Administration & Dosage]
KW  - *Family Planning Services
KW  - *Obesity/co [Complications]
KW  - *Venous Thromboembolism/pc [Prevention & Control]
KW  - *Weight Gain/de [Drug Effects]
KW  - Adult
KW  - Contraceptive Agents, Female/ae [Adverse Effects]
KW  - Contraceptives, Oral, Hormonal/ae [Adverse Effects]
KW  - Female
KW  - Humans
KW  - Obesity/ep [Epidemiology]
KW  - Practice Guidelines as Topic
KW  - Risk Assessment
KW  - United States
KW  - Venous Thromboembolism/ci [Chemically Induced]
KW  - Venous Thromboembolism/ep [Epidemiology]
KW  - Women's Health
KW  - MedStar Washington Hospital Center
KW  - Obstetrics and Gynecology/Family Planning
KW  - Journal Article
KW  - Review
N1  - Available online from MWHC library: 1996 - present
N2  - Increasing rates of obesity have become a major public health challenge. Given the added health risks that obese women have during pregnancy, preventing unwanted pregnancy is imperative. Clinicians who provide contraception must understand the efficacy, risks, and the weight changes associated with various contraceptive methods. Despite differences in the pharmacokinetics and pharmacodynamics of hormonal contraceptives in overweight and obese women, efficacy does not appear to be severely impacted. Both estrogen-containing contraceptives and obesity increase the risk of venous thromboembolism, but the absolute risk remains acceptably low in reproductive age women. Copyright (c) 2015 Elsevier Inc. All rights reserved
UR  - http://dx.doi.org/10.1016/j.ogc.2015.07.005
ER  -